Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) and reminds investors of the April 14, ...
All three of the major indexes (^DJI, ^GSPC, ^IXIC) jumped at the open. Investors are breathing a sigh of relief on reports ...
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial ...
Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The ...
Muzastotug Phase 2 dose expansion in MSS CRC with a 20 mg/kg loading dose regimen shows 33% overall response rate with four confirmed partial responses SAFEbody technology utilized to create masked ...
Trump considers tariffs on pharmaceuticals, potentially impacting imported APIs and finished drugs. Read more here.
The Philippine College of Occupational Medicine (PCOM) and healthcare company MSD in the Philippines have joined forces to ...
Plus: JetBlue CEO eyes more growth in Boston; AG Andrea Campbell offers fiery words about Trump; Charles River chamber offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback